Radioactive Tracer Market Scope And Analysis

  • Report Code : TIPRE00030001
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 150
Buy Now

Radioactive Tracer Market Report - Analysis by 2031

Buy Now


Radioactive Tracer Market Report Scope

Report Attribute Details
Market size in 2022 US$ 14.68 Billion
Market Size by 2030 US$ 54.3 Billion
Global CAGR (2022 - 2030) 17.8%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Tracer Type
  • Technetium-99m & Tc-97m
  • Iodine-131
  • Iron-59
  • Lutetium-171
  • Rubidium Chloride & Ammonia
  • Scandium-46
  • Seaborgium-269
  • Hassium-269
  • Gallium Citrate Ga 67
  • Prostate-Specific Membrane Antigen
  • FDDNP & FDOPA
  • Phosphorus-32 & Chromium-51
  • Thallium-201
  • F-18 FDG
  • F-18 FAPI
  • Ga-68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE
By Test Type
  • PET
  • SPECT
By Application
  • Oncology
  • Pulmonary
  • Neurology
  • Cardiology
By End User
  • Hospitals & Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Rotem Industries Ltd
  • Abx Advanced Biochemical Compounds Gmbh
  • Invicro Llc
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • Blue Earth Diagnostics Limited
  • General Electric Co